Newstral
Article
bizjournals.com on 2015-04-16 19:28
A surge in interest in Synta's cancer drug ahead of key science data
Related news
- MLoxo Oncology shares surge 21% on preview of cancer drug trial datamarketwatch.com
- Novogen shares surge on drug datanews.com.au
- Medicines Shares Surge on Cholesterol-Drug Datawsj.com
- College launches degree in forensics after science course interest surgeipswichstar.co.uk
- BAstraZeneca Jumps on Strong Cancer Drug Databarrons.com
- AHealth workers unions see surge in interest amid COVIDasianjournal.com
- Promising treatment seen in childhood cancer drugpressherald.com
- Medicare releases data on drug spendingpost-gazette.com
- Science, patients driving rare disease drug research surgewkrg.com
- Angelina Jolie’s story expected to spur surge in cancer screeningstriblive.com
- Can Financial Engineering And Data Science Help Cure Cancer?Forbes
- Study finds surge in hospitalizations for heroin, drug overdosespost-gazette.com
- UC Santa Cruz researchers use big data to fight cancerSanta Cruz Sentinel
- BNextCure Stock Collapses After New Cancer Drug Databarrons.com
- BBluebird Bio Gains on Promising Cancer-Drug Databarrons.com